Product Images Venlafaxine Hydrochloride

This is a drug interaction chart that shows the effects of interacting drugs, including Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium in CYP2D6 EM's and PM's. The chart also includes the analyte Venlafaxine and PK Fold Change and 90% C recommendation for Cmax and AUC. The chart provides recommendations on avoiding concurrent use or using caution while administering the drugs, especially in cases of hypertension, elderly patients, or hepatic dysfunction.*

This text appears to be a table with a list of interacting drugs and analyte PK fold change with recommendations associated with the change. The table lists several drugs, including Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, and Lithium. The recommendations for each drug are listed as "avoid concomitant use," "no dose adjustment," "use with caution," "monitor blood pressure," "no restriction," and "clinical significance unknown." The table also includes information about active moieties, Cmax, Auc, and change relative to the reference value.*

This document contains information regarding dosage recommendations for the drug venlafaxine in individuals with certain medical conditions or genetic polymorphisms. Specific populations are identified as having liver or renal impairment, CYP2D8 polymorphisms, or being over 80 years of age. Dosage adjustments are recommended for those populations. The document also includes analytical information on the drug, including Cmax and AuC data. However, some portions of the text are not decipherable ("ooV" and "ooy") and may represent errors.*

This text seems to be a random combination of letters and a drug name "venlafaxine hydrochloride". It is not possible to generate a useful description with this text as it does not provide any information or context.*

Product No. 6526-6 is a pack of 30 extended-release capsules containing 75mg of Venlafaxine hydrochloride.*